Diagnostic subgroup of myasthenia gravis is the strongest predictor of outcome

Takeaway

  • Early response to treatment predicted benign disease course in people with myasthenia gravis (MG).

Why this matters

    The results of the study can aid clinicians in predicting the prognosis of people with different subtypes of MG.